Compendium of Cancer Genome Aberrations

Changes

FEMA5:Volunteer Assignments and Opportunities (view source)

Revision as of 09:20, 27 February 2024

29,609 bytes added ,  09:20, 27 February 2024
no edit summary
Line 17: Line 17:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (TUMOURS OF THE OVARY)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Serous_borderline_tumour_of_the_ovary|Serous borderline tumour of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Low-grade_serous_carcinoma_of_the_ovary|Low-grade serous carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:High-grade_serous_carcinoma_of_the_ovary|High-grade serous carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_cystadenoma_and_adenofibroma|Mucinous cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_borderline_tumour_|Mucinous borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_carcinoma_of_the_ovary|Mucinous carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_cystadenoma_and_adenofibroma|Endometrioid cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_borderline_tumour|Endometrioid borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_carcinoma_of_the_ovary|Endometrioid carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_cystadenoma_and_adenofibroma|Clear cell cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_borderline_tumour|Clear cell borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_carcinoma_of_the_ovary|Clear cell carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Seromucinous_cystadenoma_and_adenofibroma|Seromucinous cystadenoma and adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Seromucinous_borderline_tumour|Seromucinous borderline tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Brenner_tumour_|Brenner tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Borderline_Brenner_tumour|Borderline Brenner tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Malignant_Brenner_tumour_|Malignant Brenner tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mesonephric-like_adenocarcinoma|Mesonephric-like adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_ovary|Undifferentiated and dedifferentiated carcinomas of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinosarcoma_of_the_ovary|Carcinosarcoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_carcinoma_of_the_ovary|Mixed carcinoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_ovary|Endometrioid stromal sarcoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Smooth_muscle_tumours_of_the_ovary|Smooth muscle tumours of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_myxoma_|Ovarian myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_ovary|Adenosarcoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_fibroma_|Ovarian fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Thecoma_|Thecoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Luteinized_thecoma_associated_with_sclerosing_peritonitis_|Luteinized thecoma associated with sclerosing peritonitis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sclerosing_stromal_tumour_|Sclerosing stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Microcystic_stromal_tumour_|Microcystic stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Signet-ring_stromal_tumour_|Signet-ring stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leydig_cell_tumour_|Leydig cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Steroid_cell_tumour_|Steroid cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_fibrosarcoma_|Ovarian fibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adult_granulosa_cell_tumour_|Adult granulosa cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Juvenile_granulosa_cell_tumour_|Juvenile granulosa cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sertoli_cell_tumour_|Sertoli cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sex_cord_tumour_with_annular_tubules_|Sex cord tumour with annular tubules]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sertoli-Leydig_cell_tumour|Sertoli-Leydig cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Sex_cord-stromal_tumour_NOS|Sex cord-stromal tumour NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Gynandroblastoma|Gynandroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mature_teratoma_of_the_ovary|Mature teratoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Immature_teratoma_of_the_ovary|Immature teratoma of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Dysgerminoma_|Dysgerminoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Yolk_sac_tumour_|Yolk sac tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Embryonal_carcinoma_|Embryonal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Non-gestational_choriocarcinoma_|Non-gestational choriocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_germ_cell_tumour_of_the_ovary|Mixed germ cell tumour of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Struma_ovarii_|Struma ovarii]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_carcinoid|Ovarian carcinoid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Neuroectodermal-type_tumours|Neuroectodermal-type tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Monodermal_cystic_teratoma_|Monodermal cystic teratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Somatic_neoplasms_arising_from_teratomas|Somatic neoplasms arising from teratomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Gonadoblastoma|Gonadoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_germ_cell-sex_cord-stromal_tumour,_unclassified|Mixed germ cell-sex cord-stromal tumour, unclassified]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Rete_cystadenoma,_adenoma,_and_adenocarcinoma|Rete cystadenoma, adenoma, and adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Wolffian_tumour_of_the_ovary|Wolffian tumour of the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Solid_pseudopapillary_tumour_|Solid pseudopapillary tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Small_cell_carcinoma_of_the_ovary,_hypercalcaemic_type|Small cell carcinoma of the ovary, hypercalcaemic type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Wilms_tumour_|Wilms tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Follicle_cyst|Follicle cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Corpus_luteum_cyst|Corpus luteum cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Large_solitary_luteinized_follicle_cyst|Large solitary luteinized follicle cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Hyperreactio_luteinalis|Hyperreactio luteinalis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Pregnancy_luteoma|Pregnancy luteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Stromal_hyperplasia_and_hyperthecosis|Stromal hyperplasia and hyperthecosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Fibromatosis_and_massive_oedema|Fibromatosis and massive oedema]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leydig_cell_hyperplasia|Leydig cell hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Metastases_to_the_ovary|Metastases to the ovary]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 4 (TUMOURS OF THE PERITONEUM)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Well-differentiated_papillary_mesothelial_tumour_|Well-differentiated papillary mesothelial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:_Mesothelioma_| Mesothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Serous_borderline_tumour_of_the_peritoneum|Serous borderline tumour of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Low-grade_serous_carcinoma_of_the_peritoneum|Low-grade serous carcinoma of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:High-grade_serous_carcinoma_of_the_peritoneum|High-grade serous carcinoma of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:_Leiomyomatosis_peritonealis_disseminata_| Leiomyomatosis peritonealis disseminata]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Calcifying_fibrous_tumour_|Calcifying fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Extragastrointestinal_stromal_tumour|Extragastrointestinal stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Solitary_fibrous_tumour_of_the_peritoneum|Solitary fibrous tumour of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_peritoneum|Endometrioid stromal sarcoma of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mesothelial_hyperplasia|Mesothelial hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Peritoneal_inclusion_cysts_|Peritoneal inclusion cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Transitional_cell_metaplasia|Transitional cell metaplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endosalpingiosis_of_the_peritoneum|Endosalpingiosis of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Histiocytic_nodule|Histiocytic nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ectopic_decidua|Ectopic decidua]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Splenosis|Splenosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Other_tumour-like_lesions_of_the_peritoneum|Other tumour-like lesions of the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinomas_and_sarcomas_metastatic_to_the_peritoneum|Carcinomas and sarcomas metastatic to the peritoneum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Pseudomyxoma_peritonei|Pseudomyxoma peritonei]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Gliomatosis|Gliomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Serous_borderline_tumour_of_the_fallopian_tube|Serous borderline tumour of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:High-grade_serous_carcinoma_of_the_fallopian_tube|High-grade serous carcinoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_carcinoma_of_the_fallopian_tube|Endometrioid carcinoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinosarcoma_of_the_fallopian_tube|Carcinosarcoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Paratubal_cysts|Paratubal cysts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Tubal_hyperplasia|Tubal hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Tubo-ovarian_abscess|Tubo-ovarian abscess]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Salpingitis_isthmica_nodosa|Salpingitis isthmica nodosa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Metaplastic_papillary_lesion|Metaplastic papillary lesion]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Placental_site_nodule_occurring_in_the_fallopian_tube|Placental site nodule occurring in the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucinous_metaplasia|Mucinous metaplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_fallopian_tube|Adenosarcoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Teratoma_of_the_fallopian_tube|Teratoma of the fallopian tube]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenomyoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenosarcoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leiomyosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyosarcoma of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Wolffian_tumour_of_the_broad_ligament_and_other_uterine_ligaments|Wolffian tumour of the broad ligament and other uterine ligaments]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Papillary_cystadenoma_|Papillary cystadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ependymoma_|Ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adrenocortical_remnants|Adrenocortical remnants]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrial_atypical_hyperplasia_/_endometrioid_intraepithelial_neoplasia|Endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Endometrioid_carcinoma_of_the_uterine_corpus|Endometrioid carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Serous_carcinoma_of_the_uterine_corpus|Serous carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Clear_cell_carcinoma_of_the_uterine_corpus_|Clear cell carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_uterine_corpus|Undifferentiated and dedifferentiated carcinomas of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mixed_carcinoma_of_the_uterine_corpus|Mixed carcinoma of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Other_endometrial_carcinomas|Other endometrial carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 1,512:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Carcinosarcoma_of_the_uterine_corpus|Carcinosarcoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 1,523:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endometrial_polyp|Endometrial polyp]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 1,534:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endometrial_metaplasia|Endometrial metaplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 1,545:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_corpus|Arias-Stella reaction of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 1,556:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Uterine_leiomyoma|Uterine leiomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 1,567:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Intravenous_leiomyomatosis_|Intravenous leiomyomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 1,578:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_uterine_corpus|Smooth muscle tumour of uncertain malignant potential of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 1,589:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Metastasizing_leiomyoma_|Metastasizing leiomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 1,600:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Uterine_leiomyosarcoma_|Uterine leiomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 1,611:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endometrial_stromal_nodule_|Endometrial stromal nodule]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 1,622:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Low-grade_endometrial_stromal_sarcoma_|Low-grade endometrial stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 1,633:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:High-grade_endometrial_stromal_sarcoma_|High-grade endometrial stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 1,644:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Undifferentiated_uterine_sarcoma_|Undifferentiated uterine sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 1,655:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Uterine_tumour_resembling_ovarian_sex_cord_tumour_|Uterine tumour resembling ovarian sex cord tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 1,666:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Perivascular_epithelioid_cell_tumour_(PEComa)|Perivascular epithelioid cell tumour (PEComa)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 1,677:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 1,688:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenomyoma_of_the_uterine_corpus|Adenomyoma of the uterine corpus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 1,699:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Atypical_polypoid_adenomyoma_|Atypical polypoid adenomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 1,710:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenosarcoma_of_the_uterine_corpus|Adenosarcoma of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Central_primitive_neuroectodermal_tumour_/_CNS_embryonal_tumour|Central primitive neuroectodermal tumour / CNS embryonal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Germ_cell_tumours_of_the_uterine_corpus|Germ cell tumours of the uterine corpus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 1,774:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Placental_site_nodule_and_plaque|Placental site nodule and plaque]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 1,785:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Abnormal_(non-molar)_villous_lesions|Abnormal (non-molar) villous lesions]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 1,796:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Partial_hydatidiform_mole|Partial hydatidiform mole]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 1,807:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Complete_hydatidiform_mole|Complete hydatidiform mole]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 1,818:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Invasive_and_metastatic_hydatidiform_moles|Invasive and metastatic hydatidiform moles]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 1,829:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Epithelioid_trophoblastic_tumour_|Epithelioid trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 1,840:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Placental_site_trophoblastic_tumour_|Placental site trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 1,851:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Gestational_choriocarcinoma|Gestational choriocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 1,862:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mixed_trophoblastic_tumour|Mixed trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 1,873:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 1,904:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Atrophy_of_the_uterine_cervix|Atrophy of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 1,915:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_uterine_cervix|Squamous intraepithelial lesions of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 1,926:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-associated, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 1,937:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-independent, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 1,948:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endocervical_polyp|Endocervical polyp]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 1,959:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mullerian_papilloma_of_the_uterine_cervix|Mullerian papilloma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 1,970:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Nabothian_cyst|Nabothian cyst]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 1,981:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Tunnel_clusters|Tunnel clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 1,992:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Microglandular_hyperplasia|Microglandular hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 2,003:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Lobular_endocervical_glandular_hyperplasia|Lobular endocervical glandular hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 2,014:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Diffuse_laminar_endocervical_hyperplasia|Diffuse laminar endocervical hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 2,025:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mesonephric_remnants_and_hyperplasia|Mesonephric remnants and hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 2,036:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_cervix|Arias-Stella reaction of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 2,047:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endocervicosis_of_the_uterine_cervix|Endocervicosis of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 2,058:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Tuboendometrioid_metaplasia|Tuboendometrioid metaplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 2,069:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Ectopic_prostate_tissue|Ectopic prostate tissue]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 2,080:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-associated, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 2,091:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma, HPV-associated, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 2,102:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-independent,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-independent, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 2,113:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-independent,_gastric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 2,124:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-independent,_clear_cell_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, clear cell type, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 2,135:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-independent,_mesonephric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, mesonephric type, of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 2,146:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Other_adenocarcinomas_of_the_uterine_cervix|Other adenocarcinomas of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 2,157:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Carcinosarcoma_of_the_uterine_cervix|Carcinosarcoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 2,168:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenosquamous_and_mucoepidermoid_carcinomas_of_the_uterine_cervix|Adenosquamous and mucoepidermoid carcinomas of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 2,179:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenoid_basal_carcinoma_of_the_uterine_cervix|Adenoid basal carcinoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 2,190:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Carcinoma_of_the_uterine_cervix,_unclassifiable|Carcinoma of the uterine cervix, unclassifiable]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 2,201:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenomyoma_of_the_uterine_cervix|Adenomyoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 2,212:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenosarcoma_of_the_uterine_cervix|Adenosarcoma of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 2,223:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Germ_cell_tumours_of_the_uterine_cervix|Germ cell tumours of the uterine cervix]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 2,234:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 10 (TUMOURS OF THE VAGINA)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 2,265:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Atrophy_of_the_vagina|Atrophy of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 2,276:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Tubulosquamous_polyp_|Tubulosquamous polyp]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 2,287:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_vagina|Squamous intraepithelial lesions of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 2,298:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vagina|Squamous cell carcinoma, HPV-associated, of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 2,309:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vagina|Squamous cell carcinoma, HPV-independent, of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 2,320:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Villous_adenoma_|Villous adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 2,331:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mullerian_papilloma_of_the_vagina|Mullerian papilloma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 2,342:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Vaginal_adenosis|Vaginal adenosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 2,353:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endocervicosis_of_the_vagina|Endocervicosis of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 2,364:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Cysts_of_the_vagina|Cysts of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 2,375:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_vagina|Adenocarcinoma, HPV-associated, of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 2,386:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Endometrioid_carcinoma_of_the_vagina|Endometrioid carcinoma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 2,397:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Clear_cell_carcinoma_of_the_vagina|Clear cell carcinoma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 2,408:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mucinous_carcinoma,_gastric_type,_of_the_vagina|Mucinous carcinoma, gastric type, of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 2,419:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mucinous_carcinoma,_intestinal_type,_of_the_vagina|Mucinous carcinoma, intestinal type, of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 2,430:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Mesonephric_adenocarcinoma_of_the_vagina|Mesonephric adenocarcinoma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 2,441:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[FEMA5:Carcinosarcoma_of_the_vagina|Carcinosarcoma of the vagina]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 2,452:  
|
 
|
 
|-
 
|-
 +
|[[FEMA5:Mixed_tumour_of_the_vagina|Mixed tumour of the vagina]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenocarcinoma_of_Skene_gland_origin_|Adenocarcinoma of Skene gland origin]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosquamous_carcinoma_of_the_vagina|Adenosquamous carcinoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenosarcoma_of_the_vagina_|Adenosarcoma of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Germ_cell_tumours_of_the_vagina|Germ cell tumours of the vagina]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (TUMOURS OF THE VULVA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Squamous_intraepithelial_lesions,_HPV-associated,_of_the_vulva|Squamous intraepithelial lesions, HPV-associated, of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Vulvar_intraepithelial_neoplasia,_HPV-independent|Vulvar intraepithelial neoplasia, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vulva|Squamous cell carcinoma, HPV-associated, of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vulva|Squamous cell carcinoma, HPV-independent, of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Papillary_hidradenoma_|Papillary hidradenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Chondroid_syringoma|Chondroid syringoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Fibroadenoma_|Fibroadenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Phyllodes_tumour|Phyllodes tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenocarcinoma_of_mammary_gland_type_|Adenocarcinoma of mammary gland type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Bartholin_gland_cyst|Bartholin gland cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Bartholin_gland_hyperplasia,_adenoma,_and_adenomyoma|Bartholin gland hyperplasia, adenoma, and adenomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Bartholin_gland_carcinomas|Bartholin gland carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Other_cysts_of_the_vulva|Other cysts of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Paget_disease_|Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinomas_of_sweat_gland_origin|Carcinomas of sweat gland origin]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Adenocarcinoma_of_intestinal_type_|Adenocarcinoma of intestinal type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Germ_cell_tumours_of_the_vulva|Germ cell tumours of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (NEUROENDOCRINE NEOPLASIA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carcinoma_admixed_with_neuroendocrine_carcinoma_|Carcinoma admixed with neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Follicular_lymphoma|Follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Myeloid_sarcoma|Myeloid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Lipoma_|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Lipoblastoma-like_tumour_of_the_vulva|Lipoblastoma-like tumour of the vulva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Liposarcoma_|Liposarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Postoperative_spindle_cell_nodule|Postoperative spindle cell nodule]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Fibroepithelial_stromal_polyp|Fibroepithelial stromal polyp]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Prepubertal_fibroma|Prepubertal fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Superficial_myofibroblastoma_|Superficial myofibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Myofibroblastoma_|Myofibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Cellular_angiofibroma_|Cellular angiofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Angiomyofibroblastoma_|Angiomyofibroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Solitary_fibrous_tumour_of_the_lower_genital_tract|Solitary fibrous tumour of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Dermatofibrosarcoma_protuberans_|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Kaposi_sarcoma_|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Angiosarcoma_|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leiomyoma_of_the_lower_genital_tract|Leiomyoma of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_lower_genital_tract|Smooth muscle tumour of uncertain malignant potential of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Leiomyosarcoma_of_the_lower_genital_tract|Leiomyosarcoma of the lower genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Rhabdomyoma_|Rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Benign_peripheral_nerve_sheath_tumours|Benign peripheral nerve sheath tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Granular_cell_tumour_|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Superficial_angiomyxoma_|Superficial angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Deep_(aggressive)_angiomyxoma_|Deep (aggressive) angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Epithelioid_sarcoma_|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Alveolar_soft_part_sarcoma_|Alveolar soft part sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ewing_sarcoma_|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 15 (MELANOCYTIC LESIONS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Congenital_melanocytic_naevus_|Congenital melanocytic naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Blue_naevus_|Blue naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Atypical_melanocytic_naevus_of_genital_type_|Atypical melanocytic naevus of genital type]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Dysplastic_melanocytic_naevus_|Dysplastic melanocytic naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Mucosal_melanoma_|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 16 (METASTASIS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Lynch_syndrome|Lynch syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:DICER1_syndrome_|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[FEMA5:Other genetic tumour syndromes of the female genital tract|Other genetic tumour syndromes of the female genital tract]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14039...14265"